SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 4/16/18 Glucose Health, Inc. 15-12G 4/16/18 1:6K Discount Edgar/FA |
Document/Exhibit Description Pages Size 1: 15-12G Certification of Termination of Registration of a HTML 7K Class of Securities
gluc_.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-55439
GLUCOSE HEALTH, INC. |
(Exact name of registrant as specified in its charter) |
609 SW 8th Street, Suite 600, Bentonville, AR 72712 (479) 802-3827
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock $0.001 Par Value
(Title of each class of securities covered by this Form)
NONE
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) x
Rule 12g-4(a)(2)
Rule 12h-3(b)(1)(i)
Rule 12h-3(b)(1)(ii)
Rule 15d-6 x
Approximate number of holders of record as of the certification or notice date: 121
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: April 16, 2018 | By: | /s/ Murray Fleming | |
|
|
Murray Fleming | |
Chief Executive Officer |
This ‘15-12G’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / Effective on: | 4/16/18 | None on these Dates | ||
List all Filings |